![How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy | Gene Therapy How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy | Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fgt.2017.34/MediaObjects/41434_2017_Article_BFgt201734_Fig1_HTML.jpg)
How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy | Gene Therapy
![Nusinersen (Spinraza®) – Spinal Muscular Atrophy (SMA) | National Institute of Neurological Disorders and Stroke Nusinersen (Spinraza®) – Spinal Muscular Atrophy (SMA) | National Institute of Neurological Disorders and Stroke](https://www.ninds.nih.gov/sites/default/files/styles/full_width_small/public/2022-03/smn2_rna_replacement_v2.png?itok=cHY6Rb7l)
Nusinersen (Spinraza®) – Spinal Muscular Atrophy (SMA) | National Institute of Neurological Disorders and Stroke
![Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders | Neurological Research and Practice | Full Text Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders | Neurological Research and Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42466-021-00162-9/MediaObjects/42466_2021_162_Fig2_HTML.png)
Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders | Neurological Research and Practice | Full Text
![LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts. - Abstract - Europe PMC LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5473822/bin/41598_2017_3850_Fig1_HTML.jpg)
LNA/DNA mixmer-based antisense oligonucleotides correct alternative splicing of the SMN2 gene and restore SMN protein expression in type 1 SMA fibroblasts. - Abstract - Europe PMC
![IJMS | Free Full-Text | Development of the Method for Nusinersen and Its Metabolites Identification in the Serum Samples of Children Treated with Spinraza for Spinal Muscular Atrophy IJMS | Free Full-Text | Development of the Method for Nusinersen and Its Metabolites Identification in the Serum Samples of Children Treated with Spinraza for Spinal Muscular Atrophy](https://www.mdpi.com/ijms/ijms-23-10166/article_deploy/html/images/ijms-23-10166-g001.png)
IJMS | Free Full-Text | Development of the Method for Nusinersen and Its Metabolites Identification in the Serum Samples of Children Treated with Spinraza for Spinal Muscular Atrophy
![Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders | Neurological Research and Practice | Full Text Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders | Neurological Research and Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42466-021-00162-9/MediaObjects/42466_2021_162_Fig1_HTML.png)
Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders | Neurological Research and Practice | Full Text
![IJMS | Free Full-Text | Development of the Method for Nusinersen and Its Metabolites Identification in the Serum Samples of Children Treated with Spinraza for Spinal Muscular Atrophy IJMS | Free Full-Text | Development of the Method for Nusinersen and Its Metabolites Identification in the Serum Samples of Children Treated with Spinraza for Spinal Muscular Atrophy](https://www.mdpi.com/ijms/ijms-23-10166/article_deploy/html/images/ijms-23-10166-g004.png)